Christopher Gasparis: Anticoagulation After Atrial Fibrillation Ablation – Long-Term Impact on Stroke
Christopher Gasparis, Surgery Resident at Northwell Health, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Heart Rhythm O2, adding:
“Excited to share our new ITHACA database publication in Heart Rhythm O2!
We investigated the long-term risk of stroke in select patients with elevated CHA2DS2-VASc score who discontinued anticoagulation following atrial fibrillation ablation.
A big thank you to my mentors Stavros Mountantonakis and Kristie Coleman and my coauthors Stefanos Zafeiropoulos, Jonas Leavitt, Elliot Wolf, Ari Zimmer, Rajat Goyal and Dr. Laurence Epstein for their guidance and contributions.”
Title: Anticoagulation Decision Based on Atrial Fibrillation Ablation Outcomes and Long-Term Impact on Stroke. An ITHACA Database Study
Authors: Christopher Gasparis, Stefanos Zafeiropoulos, Jonas Leavitt, Elliot Wolf, Ari Zimmer, Rajat Goyal, Laurence M. Epstein, Kristie M. Coleman, Stavros E. Mountantonakis.
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI
-
Sep 20, 2026, 09:51Ceasovschih Alexandr: A Closer Look at Lipid Disorders in CKM Syndrome
-
Sep 20, 2026, 09:05World Stroke Academy: Can Adjunct IAT Improve Tissue Reperfusion?
-
Sep 20, 2026, 06:46Neeraj Songara: From Donated Blood to Engineered Therapeutics
-
Sep 20, 2026, 06:24Louise St. Germain Bannon: Improving Awareness and Care for Women Across the Lifespan
-
Sep 20, 2026, 05:17Maxime Dely: When ABO Compatibility Isn’t Enough for Safe Transfusion
-
Sep 20, 2026, 04:54William Aird: What Does a Complete History and Physical Really Mean?